Skip to main content
. 2014 Apr 27;5(10):3273–3286. doi: 10.18632/oncotarget.1926

Figure 4. Clonogenic survival assays in control MeWo cells and PTEN knockdown (KD) MeWo cells treated with inhibitor-1.

Figure 4

(A), inhibitor-2 (B), inhibitor-3 (C) and inhibitor-4 (D) Clonogenic survival assays in MeWo, SkMel28, UACC62 and HT144 cells treated with methoxyamine (E). Clonogenic survival assays in control MeWo cells and PTEN knockdown (KD) MeWo cells treated with methoxyamine (F). Clonogenic survival assays in MeWo, SkMel28, UACC62 and HT144 cells treated with NU1025 (G). Clonogenic survival assays in control MeWo cells and PTEN knockdown (KD) MeWo cells treated with NU1025 (H). Inhibitors were added at the indicated concentrations (see methods for details). * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 compared to MeWo (PTEN-wildtype).